Core Cap Advisors, LLC Teva Pharmaceutical Industries LTD Transaction History
Core Cap Advisors, LLC
- $2.07 Billion
- Q3 2024
A detailed history of Core Cap Advisors, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Core Cap Advisors, LLC holds 1,044 shares of TEVA stock, worth $17,831. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,044Holding current value
$17,831% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding TEVA
# of Institutions
624Shares Held
573MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$734 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$619 Million35.87% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L334.5MShares$590 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$493 Million3.32% of portfolio
-
Exor Capital LLP London, X026.5MShares$453 Million14.79% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $19B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...